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To the Editor,
A one-year-old boy was referred for randomly detected hy-
peramylasemia. Physical examination was completely normal, 
including growth parameters. Medical history and family history 
were unremarkable. In laboratory, the repeated serum amylases 
were found elevated with the values of 280 IU/mL, 290 IU/mL 
and 310 IU/mL (N: 10-90 IU/mL) together with a lower urine 
amylase level of 10.5 IU/mL (N: 25-500 IU/mL). The complete 
blood count, acute-phase reactants, liver–renal–thyroid func-
tional tests, serum lipase and immunoglobulins were normal. 
Antibodies against endomysium, gliadin, thyroglobulin, thyroid 
peroxidase, nucleus and dsDNA were negative. Abdominal ul-
trasonography and computed tomography (CT) scans were nor-
mal. According to these normal findings, hyperamylasemia due 
to macroamylasemia (MA) was found in patient. An informed 
consent form to research was obtained from parents. At analysis 
for MA, a precipitated activity was 87% at polyethylene glycol 
(PEG) precipitation (MA>60%) (1). 
Macroenzymes are complexes of serum enzymes commonly 
with immunoglobulins or lipoproteins that have a higher mole-
culer weight. Macroamylase is the most common macroenzyme, 
in which pancreatic or salivary amylase binds to plasma proteins 
and cannot be excreted by renal glomeruli. Macroamylasemia 
may be seen either isolated or associated with a variety of dis-
orders, such as IgA deficiency, celiac disease, lymphoma, carci-
noma, systemic lupus erithematosus, rheumatoid arthritis, liver 
disease and various autoimmune diseases (2-4). The pathogen-
esis of macroenzyme formation in these diseases is estimated by 
‘antigen-driven’ theory: a self-antigen is altered or released from 
a sequestered site in the body and cross-reacts with an antibody 
initially formed against a foreign antigen. A second theory is the 
‘dysregulation of immune tolerance, which is likely to occur in 
autoimmune disorders (4). The cross-reactivity to either gluten-
related or other antigens resulting in autoantibody formation 
against pancreatic serum amylase at intestinal level is considered 
(5). The elevated serum amylase, low 24-hour urine amylase and 
reduced ratio of amylase clearance / creatinine clearance are im-
portant at diagnosis. It has been shown that PEG precipitation is 
also a precise method in the detection of MA by purifying pro-
tein from macromolecules more easily and quickly (1). Due to 
the problem at urine collection, PEG precipitation was preferred 
in this case. It was considered as isolated MA due to the absence 
of associated disorders. In conclusion, MA is generally a benign 
condition, but associated potential disorders should be consid-
ered at follow-up. The case highlights the dilemma of additional 
invasive explorations and unnecessary treatments by differenti-
ating MA from other situations associated to hyperamylasemia.
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